Fibrin-specific breakdown and activation of the endogenous fibrinolytic system
Fibrinolysis & Antithrombotic Enzymatic Activity · Vascular endothelium and hemodynamics
Directly breaks down cross-linked fibrin networks and stimulates vascular endothelium to release tissue-type plasminogen activator (t-PA), reducing platelet aggregation and blood viscosity.
Supplements acting on this mechanism (ranked by strength and evidence)
Lumbrokinase
Lumbrokinase can act on fibrin. A human randomized study observed higher t-PA activity and D-dimer and lower fibrinogen, so fibrinolysis-related human markers did change. However, fibrin breakdown in vitro does not show that the intact enzyme directly breaks up microthrombi in humans, and the contribution of direct enzymatic cleavage is not established.
Nattokinase
Nattokinase has direct fibrinolytic activity in vitro. A single 2000 FU dose can briefly raise fibrin degradation markers in humans, but it is unclear whether the active enzyme reaches the blood reliably. Direct cleavage of fibrin or inactivation of PAI-1 has also not been confirmed in humans.